How the most common mitochondrial DNA mutation (m.3243A>G) vanishes from leukocytes: a mathematical model

被引:6
|
作者
Veitia, Reiner A. [1 ]
机构
[1] Univ Paris Diderot, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France
关键词
MTDNA MUTATION; CLINICAL-FEATURES; M.3243A-GREATER-THAN-G MUTATION; DIABETES-MELLITUS; MELAS SYNDROME; GENE MUTATION; HETEROPLASMY; DISEASE; BLOOD; DIAGNOSIS;
D O I
10.1093/hmg/ddy063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial diseases may be caused by alterations of the mitochondrial genome. The pathogenic variant m.3243A>G is one of the most frequent causes of mitochondrial disease and the most common mitochondrial DNA mutation. Patients with a variant in mitochondrial DNA can have a mixture of mutated and wild-type genomes (heteroplasmy). In the case of the pathogenic variant m.3243A>G, the degree of heteroplasmy (H) correlates to some extent with the severity of the disease. Several longitudinal studies, where H is measured at two different time-points, have shown an annual decline in leukocyte H values. Thus far, only an exponential decay of H with time has been noted but a mechanistic model is lacking. Here, I describe a deterministic mathematical model that accounts for the decline of H in leukocytes based on selective mechanisms acting at the stem cell level. The 'inverted-sigmoid' model provides estimates of at-birth H levels closer to those observed in post-mitotic tissues, such as skeletal muscle, than the estimates provided by an exponential decay. The new model never leads to predictions of H > 100% and provides a stronger correlation between at-birth H values in leukocytes and the scores of the Newcastle Mitochondrial Disease Scale for Adults, which can be of practical utility. This model could be extended to other mitochondrial DNA disease-causing variants.
引用
收藏
页码:1565 / 1571
页数:7
相关论文
共 21 条
  • [21] m.3243A>G Mutation in Mitochondrial DNA Leads to Decreased Insulin Sensitivity in Skeletal Muscle and to Progressive β-Cell Dysfunction
    Lindroos, Markus M.
    Majamaa, Kari
    Tura, Andrea
    Mari, Andrea
    Kalliokoski, Kari K.
    Taittonen, Markku T.
    Iozzo, Patricia
    Nuutila, Pirjo
    DIABETES, 2009, 58 (03) : 543 - 549